GMJ Briefs
Announcement: Vitamin D Supplementation Could Cut Type 2 Diabetes Prevention Costs by Nearly Half, Modelling Study Suggests
New study: Vitamin D supplementation could prevent 1.2 million cases of type 2 diabetes in the U.S. over 10 years,…
Three Evidence-Based Coffee Recommendations Every Patient Should Know
Three practical coffee guidelines emerge from 2025 evidence: choose filtered preparations, consume in the morning, and recognize that moderate intake…
High-Dose Alcohol Nearly Halves Sleep Recovery, Finnish Study Finds
High-dose alcohol reduces HRV-derived recovery by 39.2% during early sleep stages, independent of physical fitness.
Announcement: WHO Prequalifies Infant-Friendly Malaria Treatment and New Diagnostic Tests
The WHO has prequalified a new artemether–lumefantrine formulation designed specifically for infants, plus 3 rapid diagnostic tests—a major step forward…
High-Intensity Training Delivers 4× Greater Mitochondrial Gains Per Unit Time
High-intensity interval training produces 4× greater mitochondrial adaptations than endurance training per unit time invested.
What You Need to Know: The Peanut-Brain Connection in Aging
A 60g daily peanut serving boosts brain blood flow by 4% via arginine-driven vasodilation—equivalent to reversing 10 years of cognitive…
Why Your Alcohol Sensitivity Differs From Your Neighbor’s: A Brain-Based Explanation
Brain network fragmentation varies between individuals and explains differing alcohol sensitivity at legal BAC limits.
Announcement: Opioid agonist treatment cuts mortality risk in French primary care—largest nationwide study yet
New nationwide French evidence: opioid agonist treatment (OAT) is associated with a large decrease in all-cause mortality, especially buprenorphine. The…